TC BIOPHARM HOLDINGS PLC-ADR (TCBP)

Company Profile

TC BioPharm Ltd is a GB-based company operating in Biotechnology industry. TC BioPharm Limited is a clinical-stage biopharmaceutical company. The firm is engaged in developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma-delta T cell therapies for the treatment of infectious disease. The firm's platform technology allows the Company to design specific therapies to treat a range of cancers and infectious diseases with off-the-shelf allogeneic gamma-delta T cell (GDT) products. The Company’s pipeline includes OmnImmune and CAR-T programs. OmnImmune is an unmodified allogeneic gamma-delta T cell product being used for the treatment of acute myeloid leukemia (AML). The firm has completed a Phase II clinical trial. Its CAR-T programs include in-house and partner programs at the pre-clinical-stage focused on developing CAR modified allogeneic gamma delta T-cell products targeting solid and hematological indications.

Company Info

TC BIOPHARM HOLDINGS PLC-ADR

Maxim 1, 2 Parklands Way

Honiton

Employees: 77

Website: https://tcbiopharm.com/